Table 4.
Summary of pediatric literature on renal transplantation post-HCT.
| Age at HCT | Time to renal transplant | Transplant type | Underlying oncologic and renal diagnosis | Current graft survival | Post-renal transplant complications | |
|---|---|---|---|---|---|---|
| 53 | 2y | 10y | LRKT (pre-emptive) |
-Stage III neuroblastoma -Interstitial fibrosis |
6y | None |
| 7y | 1y | LRKT (hemodialysis prior) | -Schimke’s immune-osseous dysplasia -Mesangioproliferative glomerulonephritis |
3y 8m | None | |
| 4y | 10y | LRKT (pre-emptive) |
-Stage IV neuroblastoma -Interstitial fibrosis |
7m | Tacrolimus toxicity | |
| 91 | 15y | 32m | LRKT (pre-emptive) |
-Erythropoietic porphyria -CKD following 2 HCTs and prolonged foscarnet for CMV reactivation |
1.7y | None |
| 6y | 28m | DDKT (hemodialysis prior) | -Neuroblastoma -TA-TMA requiring bilateral nephrectomies |
1.5y | CKD |
Living related kidney transplant (LRKT) and deceased donor kidney transplant (DDKT). Pre-emptive refers to patients who were transplanted before starting dialysis.